Alexander N. Gorelick, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA, Mitochondrial | 3 | 2024 | 865 | 0.700 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 495 | 0.630 |
Why?
|
| Oncogenes | 3 | 2022 | 1221 | 0.530 |
Why?
|
| DNA, Neoplasm | 1 | 2021 | 1743 | 0.510 |
Why?
|
| Longevity | 1 | 2022 | 1064 | 0.460 |
Why?
|
| Genome, Mitochondrial | 2 | 2024 | 66 | 0.410 |
Why?
|
| Cell Lineage | 1 | 2021 | 2554 | 0.390 |
Why?
|
| Models, Genetic | 1 | 2020 | 3431 | 0.350 |
Why?
|
| Mutation | 12 | 2024 | 30016 | 0.310 |
Why?
|
| Neoplasms | 8 | 2024 | 22131 | 0.260 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2024 | 682 | 0.170 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2021 | 295 | 0.170 |
Why?
|
| Alleles | 3 | 2022 | 6861 | 0.170 |
Why?
|
| Nuclear Export Signals | 1 | 2019 | 9 | 0.170 |
Why?
|
| Receptor, trkA | 1 | 2020 | 159 | 0.170 |
Why?
|
| Colonic Neoplasms | 2 | 2023 | 2533 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2024 | 5304 | 0.150 |
Why?
|
| Breast Neoplasms, Male | 1 | 2019 | 212 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2024 | 1404 | 0.150 |
Why?
|
| Genes, p53 | 1 | 2020 | 712 | 0.150 |
Why?
|
| DNA Copy Number Variations | 2 | 2024 | 2020 | 0.150 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2019 | 332 | 0.150 |
Why?
|
| Liver Neoplasms | 2 | 2023 | 4308 | 0.140 |
Why?
|
| Selection, Genetic | 1 | 2020 | 868 | 0.130 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 899 | 0.120 |
Why?
|
| Cell Nucleus | 1 | 2024 | 2894 | 0.120 |
Why?
|
| Telomerase | 1 | 2020 | 744 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 1739 | 0.120 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 1988 | 0.120 |
Why?
|
| Gene Dosage | 1 | 2018 | 1217 | 0.110 |
Why?
|
| Benzimidazoles | 1 | 2019 | 858 | 0.110 |
Why?
|
| Benchmarking | 1 | 2020 | 1045 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 2456 | 0.110 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2447 | 0.100 |
Why?
|
| Mitochondria | 2 | 2024 | 3619 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2022 | 5672 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2208 | 0.100 |
Why?
|
| RNA | 1 | 2021 | 2713 | 0.090 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 16967 | 0.090 |
Why?
|
| Genotype | 2 | 2022 | 12978 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 2291 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2821 | 0.080 |
Why?
|
| Receptor, erbB-2 | 1 | 2019 | 2553 | 0.080 |
Why?
|
| Thyroid Neoplasms | 1 | 2022 | 2332 | 0.080 |
Why?
|
| Apoptosis | 1 | 2024 | 9476 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 2734 | 0.080 |
Why?
|
| Genome, Human | 1 | 2021 | 4421 | 0.070 |
Why?
|
| Animals | 7 | 2024 | 168201 | 0.070 |
Why?
|
| Mice | 6 | 2024 | 81368 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2019 | 3164 | 0.060 |
Why?
|
| gamma Catenin | 1 | 2023 | 44 | 0.050 |
Why?
|
| Phenotype | 1 | 2021 | 16571 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 4250 | 0.050 |
Why?
|
| Protein Binding | 3 | 2019 | 9345 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8542 | 0.050 |
Why?
|
| Oxyphil Cells | 1 | 2022 | 56 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 6925 | 0.050 |
Why?
|
| Humans | 16 | 2024 | 760617 | 0.050 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 77 | 0.040 |
Why?
|
| Genes, bcl-2 | 1 | 2019 | 119 | 0.040 |
Why?
|
| Leukemia, B-Cell | 1 | 2019 | 84 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11736 | 0.040 |
Why?
|
| Karyopherins | 1 | 2019 | 133 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13382 | 0.040 |
Why?
|
| Genes, myc | 1 | 2019 | 390 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2019 | 427 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2019 | 433 | 0.040 |
Why?
|
| Lymphoma, B-Cell | 1 | 2024 | 938 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 669 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2017 | 265 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 17878 | 0.030 |
Why?
|
| Codon | 1 | 2017 | 600 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2019 | 1755 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 20988 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 858 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2024 | 1977 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2019 | 1964 | 0.030 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 1405 | 0.030 |
Why?
|
| Quinolines | 1 | 2019 | 764 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3074 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2864 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 3607 | 0.030 |
Why?
|
| Thiazoles | 1 | 2019 | 1517 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 4110 | 0.020 |
Why?
|
| Binding Sites | 1 | 2019 | 6051 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 2057 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4269 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3868 | 0.020 |
Why?
|
| Female | 4 | 2020 | 392148 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4739 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2024 | 9586 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2020 | 6233 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 7568 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2020 | 54360 | 0.020 |
Why?
|
| Genomics | 1 | 2019 | 5822 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10432 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18221 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 23416 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 220969 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58894 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 64568 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 169042 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 220584 | 0.000 |
Why?
|
| Male | 1 | 2019 | 360358 | 0.000 |
Why?
|